NCT04324723

Brief Summary

The study had two stages. Stage 1 involved an opportunistic screening for hypertension conducted at the 2018 Beirut Marathon. During stage 1, participants whose measurements indicated hypertension were invited to take part in a RCT (randomized controlled trial). Stage 2 involved a RCT to evaluate the effectiveness of a behavioural intervention to increase the proportion of participants who sought further medical attention. The research team hypothesised that the intervention would increase the proportion of participants who sought further medical attention compared to a control group that did not receive the intervention. This is a retrospective registration specifically focused on the RCT component of this study. The study was conducted by Nudge Lebanon in partnership with B4- development (formerly known as QBIU) and SmartScience. The RCT was not pre-registered because the collaborators were unaware that pre-registration would be necessary. The collaborators asked the University of Warwick to re-analyse and write the project up for publication after the study was complete. The University of Warwick is now seeking to retrospectively register the trial before submitting to an academic journal. The fact that this trial is retrospectively registered will be plainly stated in the manuscript and all analyses will be presented as exploratory.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
266

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
Completed

Started Nov 2018

Shorter than P25 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2019

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

March 23, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 27, 2020

Completed
Last Updated

March 27, 2020

Status Verified

March 1, 2020

Enrollment Period

2 months

First QC Date

March 23, 2020

Last Update Submit

March 25, 2020

Conditions

Keywords

Health Seeking BehaviourOpportunistic ScreeningRandomised Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Self-reported seeking of further medical attention.

    If participants tell the researcher that they sought further medical attention via a phone call they received approximately 1 month after the WhatsApp messages were sent to participants.

    Response taken 56 days after the opportunistic screening (1 = Yes-sought further medical attention, 0 = No)

Secondary Outcomes (5)

  • Self-reported Hypertension

    A survey response taken at the opportunistic screening.(1 = Yes-experiencing hypertension, 0 = No)

  • Self-reported Diabetes

    A survey response taken at the opportunistic screening.(1 = Yes-experiencing diabetes, 0 = No)

  • Self-reported High Cholesterol

    A survey response taken at the opportunistic screening.(1 = Yes-experiencing high cholesterol, 0 = No)

  • Systolic blood pressure (SBP)

    An objective measure taken at the opportunistic screening using an Omron 5 Series BP742N blood pressure monitor

  • Diastolic blood pressure (DBP)

    An objective measure taken at the opportunistic screening using an Omron 5 Series BP742N blood pressure monitor

Other Outcomes (13)

  • Heart rate

    An objective measure taken at the opportunistic screening using an Omron 5 Series BP742N blood pressure monitor

  • year of birth

    A survey response taken at the opportunistic screening.

  • Height in cm

    A survey response taken at the opportunistic screening.

  • +10 more other outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Participants in this group received a WhatsApp message reminding them to seek further medical attention for their measurement indicated hypertensive condition.

Behavioral: WhatsApp message

Control

NO INTERVENTION

Participants in this group did not received a WhatsApp message reminding them to seek further medical attention for their measurement indicated hypertensive condition.

Interventions

The experimentally evaluated part of the intervention is a WhatsApp message. The message translated from Arabic to English appears below. "Dear \[First name\], Your BP reading during Beirut Marathon was \[reading\]. This indicates that you have elevated blood pressure. You should seek medical attention at your earliest convenience. Your wellbeing matters to us. Nudge Lebanon team"

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • objectively taken measurements at opportunistic screening indicated hypertension,
  • provided informed consented to participate in the trial, and
  • provided valid contact details for a smart phone with WhatsApp messenger

You may not qualify if:

  • n/a

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nudge Lebanon. 3rd Floor, GS Building, Sit Nasab Street

Beirut, Lebanon

Location

MeSH Terms

Conditions

HypertensionHealth Behavior

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesBehavior

Study Officials

  • Fadi Makki, PhD

    B4Development Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The researchers who called participants to ask if they sought further medical attention was not made aware of the participants' conditions.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 23, 2020

First Posted

March 27, 2020

Study Start

November 7, 2018

Primary Completion

January 10, 2019

Study Completion

January 10, 2019

Last Updated

March 27, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

The research team will cannot make identifiable individual participant data available. The de-identified participant data used in this papers analyses can be made available by contacting Kelly Ann Schmidtke (ORCID identifier: 0000-0001-5993-0358) and can be reused for further analyses.

Locations